Agios Pharmaceuticals, Inc.
AGIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001439222
In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.45B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Agios Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 186 | 2 | 165 | −19 |
| Shares | 65.9M | 106.6K | 60.9M | −4.92M (−7.5%) |
| Value | $3.63B | $5.87M | $2.81B | −$816.3M (−22.5%) |
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Agios Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management SA | 104,932 | $4.84M | 0.01% |
| Citadel Advisors LLC | 98,482 | $4.54M | 0.01% |
| Maverick Capital LtdSuperinvestorMaverick Capital | 26,960 | $1.24M | 0.01% |
| Voloridge Investment Management, LLC | 17,439 | $805.0K | 0.01% |
| AGF Investments LLC | 14,060 | $649.0K | 0.06% |
| Seelaus Asset Management LLC | 14,015 | $647.0K | 0.38% |
| Millennium Management LLC | 13,588 | $627.0K | 0.00% |
| Bank of Nova Scotia | 10,908 | $503.0K | 0.00% |
| Public Employees Retirement System of Ohio | 9,000 | $415.0K | 0.00% |
| Janus Henderson Group PLC | 6,320 | $292.0K | 0.00% |
| Group One Trading, L.P. | 4,914 | $227.0K | 0.00% |
| Agf Investments Inc. | 4,200 | $194.0K | 0.00% |
| Neo Ivy Capital Management | 2,780 | $149.0K | 0.17% |
| Quantbot Technologies LP | 160 | $7.00K | 0.00% |
| Patriot Financial Group Insurance Agency, LLC | 150 | $7.00K | 0.00% |
| Bell Investment Advisors, Inc | 82 | $4.00K | 0.00% |
| O'Shaughnessy Asset Management, LLC | 40 | $2.00K | 0.00% |
| First Horizon Advisors, Inc. | 12 | $0 | 0.00% |
Sold out (37)
Institutions that held Agios Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
Not filed for Q3 2021 yet (2)
Institutions that held Agios Pharmaceuticals, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 106,557 | $5.87M |
| CWM, LLC | 7 | $0 |